The beneficial role of left ventricular assist device destination therapy in the reversal of contraindications to cardiac transplantation

To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.jtcvs.2005.02.014 Byline: Cliff K. Choong (a), Michael K. Pasque (a), Kim Shelton (b), Beth Kehoe-Huck (b), Gregory A. Ewald (b), Douglas Horstmanshof (b), Nader Moazami (a) Author Affiliation: (a) Division of Cardiothoracic Surgery, Washington University School of Medicine, St Louis, Mo. (b) Division of Cardiology, Washington University School of Medicine, St Louis, Mo. Article History: Received 2 December 2004; Revised 28 December 2004; Accepted 10 February 2005